Browsing Tag
Bain Capital
39 posts
Dhoot Transmission sets Rs 829 to Rs 871 IPO price band as Bain Capital reduces stake
Dhoot Transmission Limited is seeking up to â‚ą3,066.89 crore through a fresh issue and shareholder sale. Revenue growth and electric-vehicle exposure support the offering, but narrowing margins, customer concentration and a sizeable Bain Capital monetisation complicate the valuation case.
Travis Kalanick’s Atoms secures $1.7bn to scale physical AI businesses
Atoms has secured $1.7 billion in debt and equity financing led by Andreessen Horowitz, giving Travis Kalanick’s industrial AI venture fresh capital to automate mining, food production, construction and transport.
Craneware (AIM: CRW) falls 8% as cyber incident adds to post-warning pressure
Craneware has contained a cyber incident without interrupting its healthcare software services, but the theft of employee, customer and partner records has deepened investor anxiety following a recent profit warning and a substantial decline in the company’s market value.
Deluxe Corporation (DLX) to acquire Celero Commerce for $625m in all-cash payments transformation deal
Deluxe Corporation ($DLX) to acquire Celero Commerce for $625M in all-cash deal, accelerating payments transformation. Full executive analysis on the LLR exit here.
Man Group’s Abu Dhabi licence push strengthens ADGM’s claim in the global asset management race
Man Group wants a deeper Abu Dhabi base. ADGM’s asset management race is turning into a test of where global capital wants to sit next.
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Kailera Therapeutics priced its IPO at $16 to raise $625M. Read what the deal means for KLRA, obesity drug competition, and biotech funding now.
Insilico Medicine just doubled down on CNS with Tenacia. Here’s why that matters now.
Insilico Medicine has expanded its Tenacia CNS partnership in a deal worth up to $94.75 million. Read what it signals for AI drug discovery now.
Bridgepoint and Triton walk away from Spire Healthcare (LSE: SPI) as board keeps formal sale process alive with remaining bidders
Bridgepoint and Triton have walked away from Spire Healthcare's sale process. Find out what it means for SPI shareholders and what happens next. Read more.
Perpetual (ASX: PPT) to sell wealth management unit to Bain Capital for A$500m as private equity bets on Australia’s growing advice market
Perpetual agrees to sell its A$21.9bn wealth management arm to Bain Capital for A$500m. What this means for PPT shareholders and Australia's advice market. Read more.
OpenText to sell Vertica to Rocket Software as leadership transition sharpens enterprise AI focus
OpenText Corporation is divesting Vertica and appointing a new chief executive officer. Find out what this reset means for enterprise AI, debt reduction, and investors.